Takagi Hidenobu, Ota Hideki, Natsuaki Yutaka, Komori Yoshiaki, Ito Koki, Saiki Yoshikatsu, Takase Kei
Department of Diagnostic Radiology, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Siemens Medical Solutions USA, 10945, Le Conte Ave, Suite 3371, Los Angeles, CA, 90095-7206, USA.
Jpn J Radiol. 2015 Dec;33(12):749-56. doi: 10.1007/s11604-015-0490-6. Epub 2015 Oct 26.
This study assessed Adamkiewicz artery (AKA) detectability using multidetector computed tomography angiography (MDCTA) and time-resolved magnetic resonance angiography (MRA) at 3 T.
This Institutional Review Board-approved retrospective study included 117 patients with thoracoabdominal aortic disease scheduled for aortic repair. A total of 111 patients underwent MDCTA for AKA identification; 43 patients whose AKA identification was not definitive on MDCTA underwent additional MRA. The remaining six patients, who were not indicated for iodine-contrast MDCTA, underwent only MRA. Two reviewers independently evaluated both MDCTA and MRA data. The 4-point confidence index was used. Grades 3-4 were considered sufficient for AKA diagnosis.
AKA detectability was at 80.2% (89/111) using MDCTA and 89.8% (44/49) with MRA. In the 43 patients who underwent both MDTCA and MRA, the AKA detectability and consensus grades were significantly elevated using MRA vs. MDCTA (detectability: 88.4 vs. 69.8%, respectively, p = 0.043). AKA detectability was also higher in aortic aneurysm than aortic dissection patients on MDCTA (90.9 vs. 69.6%, respectively, p < 0.01), but not on MRA (92.9 vs. 88.6%, respectively, p = 0.99).
Time-resolved MRA at 3 T increases AKA detectability and is recommended for patients without definitive AKA identification on MDCTA.
本研究评估了在3T条件下使用多排螺旋计算机断层血管造影(MDCTA)和时间分辨磁共振血管造影(MRA)检测Adamkiewicz动脉(AKA)的可行性。
本项经机构审查委员会批准的回顾性研究纳入了117例计划进行主动脉修复的胸腹主动脉疾病患者。共有111例患者接受了MDCTA以识别AKA;43例在MDCTA上AKA识别不明确的患者接受了额外的MRA检查。其余6例不适合碘对比剂MDCTA检查的患者仅接受了MRA检查。两名阅片者独立评估MDCTA和MRA数据。采用4分置信指数。3-4级被认为足以诊断AKA。
使用MDCTA时AKA的可检测率为80.2%(89/111),使用MRA时为89.8%(44/49)。在43例同时接受MDTCA和MRA检查的患者中,与MDCTA相比,使用MRA时AKA的可检测率和一致性分级显著提高(可检测率分别为88.4%和69.8%,p = 0.043)。在MDCTA上,主动脉瘤患者的AKA可检测率也高于主动脉夹层患者(分别为90.9%和69.6%,p < 0.01),但在MRA上无此差异(分别为92.9%和88.6%,p = 0.99)。
3T时间分辨MRA可提高AKA的可检测率,推荐用于在MDCTA上AKA识别不明确的患者。